Stock PASG PASSAGE BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Passage Bio, Inc.

Equities

PASG

US7027121000

Market Closed - Nasdaq
Other stock markets
 01:30:00 16/05/2024 am IST 		5-day change 1st Jan Change
1.28 USD -3.40% Intraday chart for Passage Bio, Inc. -14.67% +26.73%
03:52pm Canaccord Genuity Trims Price Target on Passage Bio to $13 From $14, Maintains Buy Rating MT
04/03 Passage Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
PASSAGE BIO, INC. Stock Passage Bio, Inc.
 8.16Cr - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 11TCr
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 11TCr
BIONTECH SE Stock BioNTech SE
 2.22TCr -
ARGENX SE Stock argenx SE
 2.13TCr -
GENMAB A/S Stock Genmab A/S
 1.9TCr
  1. Stock Market
  2. Equities
  3. PASG Stock
  4. Charts Passage Bio, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW